Long-lasting medications may improve treatment satisfaction for opioid use disorder
NIH leaders emphasize the importance of patient voices in addiction medication development
2021-05-10
(Press-News.org) WHAT: A commentary from leaders at the National Institute on Drug Abuse, part of the NIH, discusses a new study showing that an extended-release injection of buprenorphine, a medication used to treat opioid use disorder, was preferred by patients compared to immediate-release buprenorphine, which must be taken orally every day. Extended-release formulations of medications used to treat opioid use disorder may be a valuable tool to address the current opioid addiction crisis and reduce its associated mortality. The study and the accompanying commentary were published May 10, 2021 in JAMA Network Open.
It is well established that medications used to treat opioid use disorder are highly effective in preventing relapse into drug taking, facilitating recovery, and preventing overdoses. However, retention rates for these drugs are quite low, and 40% to 50% of patients treated with methadone or buprenorphine relapse within six months of starting treatment. Though extended-release formulations of these drugs are at least as efficacious as the daily, immediate release formulations, little is known about what patients want, and how they respond to different approaches to this treatment.
In the new study, which was not funded by the NIH, investigators in Australia conducted a randomized trial to compare patient-reported outcomes for daily sublingual buprenorphine treatment (tablets given under the tongue) to a weekly or monthly injection of extended-release buprenorphine for opioid use disorder. The researchers found that the extended-release injection of buprenorphine was well-tolerated, acceptable to patients, and produced generally more positive patient-reported outcomes (including overall patient satisfaction, effectiveness, and convenience) compared to daily oral buprenorphine. There were no significant differences in illicit opioid use or side effects between the two study groups.
In the accompanying commentary, NIDA leaders note that, too often, patient voices have been left behind in medication development. They argue that using patient preferences and patient-reported outcomes as measures of interest, rather than drug abstinence, fills an important research gap and may prove to be useful in medication trials moving forward. The NIDA authors also note that extended-release formulations may offer particular benefits in settings where patients have difficulty accessing consistent care - such as justice settings, populations experiencing homelessness, and in rural communities - as well as in reducing fentanyl-related overdoses in the current opioid epidemic. However, they stress that patient-reported outcomes for these treatment options should be studied in other systems of care to determine whether these findings are consistent.
INFORMATION:
ARTICLES:
WM Compton and ND Volkow. Extended-Release Buprenorphine and Its Evaluation With Patient-Reported Outcomes. JAMA Network Open. DOI: 10.1001/jamanetworkopen.2021.9708
N Lintzeris et al. Patient Reported Outcomes of Treatment of Opioid Dependence with Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Network Open. DOI: 10.1001/jamanetworkopen.2021.9041
WHO:
Nora D. Volkow, M.D., Director of the National Institute on Drug Abuse is available for interviews.
About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit http://www.drugabuse.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health®
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-10
Scientists at UC San Francisco are learning how immune cells naturally clear the body of defunct - or senescent - cells that contribute to aging and many chronic diseases. Understanding this process may open new ways of treating age-related chronic diseases with immunotherapy.
In a healthy state, these immune cells - known as invariant Natural Killer T (iNKT) cells - function as a surveillance system, eliminating cells the body senses as foreign, including senescent cells, which have irreparable DNA damage. But the iNKT cells become less active with age and other factors like obesity that contribute to chronic disease.
Finding ways to stimulate this natural surveillance system offers an alternative to senolytic ...
2021-05-10
A new study in Current Biology from the Institute of Genomics of the University of Tartu, Estonia has shed light on the genetic prehistory of populations in modern day Italy through the analysis of ancient human individuals during the Chalcolithic/Bronze Age transition around 4,000 years ago. The genomic analysis of ancient samples enabled researchers from Estonia, Italy, and the UK to date the arrival of the Steppe-related ancestry component to 3,600 years ago in Central Italy, also finding changes in burial practice and kinship structure during this transition.
In the last years, the genetic history of ancient individuals has been extensively studied focusing on ...
2021-05-10
Northwestern University researchers are building social bonds with beams of light.
For the first time ever, Northwestern engineers and neurobiologists have wirelessly programmed -- and then deprogrammed -- mice to socially interact with one another in real time. The advancement is thanks to a first-of-its-kind ultraminiature, wireless, battery-free and fully implantable device that uses light to activate neurons.
This study is the first optogenetics (a method for controlling neurons with light) paper exploring social interactions within groups of animals, which was previously impossible with current technologies.
The research will be published May 10 in the journal ...
2021-05-10
There are billions of neurons in the human brain, and scientists want to know how they are connected. Cold Spring Harbor Laboratory (CSHL) Alle Davis and Maxine Harrison Professor of Neurosciences Anthony Zador, and colleagues Xiaoyin Chen and Yu-Chi Sun, published a new technique in Nature Neuroscience for figuring out connections using genetic tags. Their technique, called BARseq2, labels brain cells with short RNA sequences called "barcodes," allowing the researchers to trace thousands of brain circuits simultaneously.
Many brain mapping tools allow neuroscientists to examine a handful of individual neurons at a time, for example by injecting them with dye. Chen, a postdoc in Zador's lab, explains how their tool, BARseq, is different:
"The idea here is that instead ...
2021-05-10
The COVID-19 pandemic has spurred genomic surveillance of viruses on an unprecedented scale, as scientists around the world use genome sequencing to track the spread of new variants of the SARS-CoV-2 virus. The rapid accumulation of viral genome sequences presents new opportunities for tracing global and local transmission dynamics, but analyzing so much genomic data is challenging.
"There are now more than a million genome sequences for SARS-CoV-2. No one had anticipated that number when we started sequencing this virus," said Russ Corbett-Detig, assistant professor of biomolecular engineering at UC Santa Cruz.
The sheer number of coronavirus genome sequences and their rapid accumulation makes it hard to place new sequences on a "family ...
2021-05-10
PHILADELPHIA-- New research performed in mice models at Penn Medicine shows, mechanistically, how the infant lung regenerates cells after injury differently than the adult lung, with alveolar type 1 (AT1) cells reprograming into alveolar type 2 (AT2) cells (two very different lung alveolar epithelial cells), promoting cell regeneration, rather than AT2 cells differentiating into AT1 cells, which is the most widely accepted mechanism in the adult lung. These study findings, published today in Cell Stem Cell, show that the long-held assumption that AT1 ...
2021-05-10
HOUSTON - (May 10, 2021) - The prospects for life on a given planet depend not only on where it forms but also how, according to Rice University scientists.
Planets like Earth that orbit within a solar system's Goldilocks zone, with conditions supporting liquid water and a rich atmosphere, are more likely to harbor life. As it turns out, how that planet came together also determines whether it captured and retained certain volatile elements and compounds, including nitrogen, carbon and water, that give rise to life.
In a study published in Nature Geoscience, Rice graduate student and lead author Damanveer Grewal and Professor Rajdeep Dasgupta show the competition between the time it takes for material to accrete into a protoplanet and the time the protoplanet ...
2021-05-10
ITHACA, N.Y. - Voyager 1 - one of two sibling NASA spacecraft launched 44 years ago and now the most distant human-made object in space - still works and zooms toward infinity.
The craft has long since zipped past the edge of the solar system through the heliopause - the solar system's border with interstellar space - into the interstellar medium. Now, its instruments have detected the constant drone of interstellar gas (plasma waves), according to Cornell University-led research published in Nature Astronomy.
Examining data slowly sent back from more than 14 billion miles away, Stella Koch Ocker, a Cornell doctoral student in astronomy, has uncovered the emission. "It's very faint and monotone, because ...
2021-05-10
Speech problems such as stammering or stuttering plague millions of people worldwide, including 3 million Americans. President Biden himself struggled with stuttering as a child and has largely overcome it with speech therapy. The cause of stuttering has long been a mystery, but researchers at Tufts University are beginning to unlock its causes and a strategy to develop potential treatments using a very curious model system - songbirds. In a study published today in Current Biology, the researchers were able to observe that a simple, reversible pharmacological treatment in zebra finches can stimulate rapid firing in a part of the brain that leads ...
2021-05-10
Numerous disease development processes are linked to epigenetic modulation. One protein involved in the process of modulation and identified as an important cancer marker is BRD4. A recent study by the research group of Giulio Superti-Furga, Principal Investigator and Scientific Director at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, now shows that the supply of purines as well as the purine synthesis of a cell can influence BRD4 activity and thus play a role in the carcinogenesis process. The findings were published in Nature Metabolism.
Chromatin is a ...
LAST 30 PRESS RELEASES:
[Press-News.org] Long-lasting medications may improve treatment satisfaction for opioid use disorder
NIH leaders emphasize the importance of patient voices in addiction medication development
